John Noseworthy - UnitedHealth Group Independent Director
| UNH Stock | MXN 12,094 446.15 3.83% |
Director
Dr. John H. Noseworthy, M.D. is Independent Director of the Company. Dr. Noseworthy served as president and CEO of Mayo Clinic from 2009 until his retirement in 2018, leading one of the largest and most prestigious academic health systems in the United States, with 12 billion in annual revenues and 68, 000 employees. With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than 1 million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked No. 1 in the nation by U.S. News World Report . Prior to his appointment as CEO, Dr. Noseworthy served as chair of Mayo Clinic Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board. Dr. Noseworthy received his M.D. degree from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School. He joined Mayo Clinic in 1990. He is the author of more than 150 research papers, chapters, editorials and several books, including the threevolumeNeurological Therapeutics Principles and Practice, now in its second edition. He also served as editorinchief of Neurology, the official journal of the American Academy of Neurology. since 2019.
| Age | 68 |
| Tenure | 5 years |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Luis Platas | Grupo Sports World | N/A | |
| Hector Rivero | Grupo Sports World | N/A | |
| Eugene Sperling | United States Steel | 60 | |
| Patricia Tracey | United States Steel | 67 | |
| Dan Dinges | United States Steel | 65 | |
| Paul Mascarenas | United States Steel | 57 | |
| Alfredo Torrado | Grupo Sports World | N/A | |
| Michael McGarry | United States Steel | 61 | |
| John Engel | United States Steel | 57 | |
| Patricia Menendez | Grupo Sports World | N/A | |
| John Faraci | United States Steel | 69 | |
| Murry Gerber | United States Steel | 66 | |
| Omar Serio | Grupo Sports World | N/A | |
| Michael Salvino | DXC Technology | 58 | |
| Scott Thomson | The Bank of | 53 | |
| Fabian Castro | Grupo Sports World | N/A | |
| Fernando Lopez | Grupo Sports World | 35 | |
| Stephen Girsky | United States Steel | 56 | |
| Cynthia Ayon | Grupo Sports World | 52 | |
| Andrea Fossa | Grupo Sports World | N/A | |
| Humberto Herrera | Grupo Sports World | 46 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | ||
| Richard Burke, Independent Chairman of the Board | ||
| Valerie Rice, Independent Director | ||
| Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director | ||
| Sir Witty, CEO Director | ||
| Stephen Hemsley, Non-Executive Chairman of the Board | ||
| John Rex, Chief Financial Officer, Executive Vice President | ||
| Dirk McMahon, Chief Executive Officer - UnitedHealthcare | ||
| Zachary Sopcak, VP Relations | ||
| John Noseworthy, Independent Director | ||
| Jennifer Smoter, VP Officer | ||
| William Ballard, Independent Director | ||
| Glenn Renwick, Independent Director | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Ex Officer | ||
| Michele Hooper, Independent Director | ||
| Timothy Flynn, Independent Director | ||
| Thomas Roos, Senior Vice President, Chief Accounting Officer | ||
| Matthew Friedrich, Executive Vice President Chief Legal Officer | ||
| D Wilson, Executive Vice President - Human Capital | ||
| F McNabb, Independent Director | ||
| Marianne Short, Executive Vice President Chief Legal Officer | ||
| David Wichmann, CFO, Executive Vice President and Presidentident - UnitedHealth Group Operations | ||
| Brian Thompson, Ex UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 9.95 T | |||
| Shares Outstanding | 934.35 M | |||
| Shares Owned By Insiders | 0.46 % | |||
| Shares Owned By Institutions | 89.00 % | |||
| Price To Earning | 25.88 X | |||
| Price To Book | 6.64 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for UnitedHealth Stock Analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.